Complete resection of tumor tissue remains one of the most important factors for survival in patients with cancer. Surgical removal is the most common front-line cancer therapy. Tumor resection in the brain is exceptionally difficult because leaving residual tumor tissue leads to decreased survival and removing normal healthy brain tissue leads to life-long neurological deficits. Brain surgery requires a very high degree of dexterity, accurate navigation, and niicro-precision cutting over long durations;thus it is an idel candidate for robotically assisted surgery. However, tumor resection is compounded by the need to make a small opening (keyhole) in the skull, and the difficulty of distinguishing normal from diseased tissue in an intraoperative setting. A minimally-invasive robotic system that allows surgeons to directly visualize and accurately discriminate neoplastic (cancer) from non-neoplastic tissue in a real-time intra-operative setting is currently not available, but an ideal gal for NRI. We propose to overcome two major limitations affecting robotically-assisted surgery in a team approach: inability to (1) automatically and (2) optically guide treatments in a miriimally-invasive intraoperative environment with advanced photonics and new cancer biomarkers. Dr. Hannaford will lead the integration of the RAVEN II open hardware and softvvare robotic system with laser-based endoscopic imaging. A single robot arm will hold a standard surgical tool for resecting/removing tumor, and a novel scanning fluorescence and reflectance imaging system to provide the advanced photonics in an ultra-small size. A team of three research neurosurgeons (Drs. Olson, Ellenbogen, Sekhar) will help develop clinically relevant phantoms and biological models of future image-guided brain surgery. PI, Dr. Seibel will provide a new multi-modal scanning fiber endoscope (mmSFE) technology that allows advanced laser imaging, diagnostic, and therapeutic biophotonics approaches to intra-operative keyhole surgery for improved performance and safety.

Public Health Relevance

Minimally-invasive, advanced biomedical imaging is required to distinguish between healthy and cancerous brain tissue during a keyhole robotic surgical procedure. This research project develops new fluorescence cancer imaging techniques and effective robot-assisted surgical procedures for enhancing cancer treatment which encourages multidisciplinary engineering graduate study with three participating neurosurgeons.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Research Project (R01)
Project #
5R01EB016457-02
Application #
8511630
Study Section
Special Emphasis Panel (ZEB1-OSR-A (M1))
Program Officer
Krosnick, Steven
Project Start
2012-09-01
Project End
2016-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
2
Fiscal Year
2013
Total Cost
$303,336
Indirect Cost
$93,933
Name
University of Washington
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Yang, Chenying; Hou, Vivian W; Girard, Emily J et al. (2014) Target-to-background enhancement in multispectral endoscopy with background autofluorescence mitigation for quantitative molecular imaging. J Biomed Opt 19:76014
McVeigh, Patrick Z; Sacho, Raphael; Weersink, Robert A et al. (2014) High-resolution angioscopic imaging during endovascular neurosurgery. Neurosurgery 75:171-80; discussion 179-80
Yang, Chenying; Hou, Vivian; Nelson, Leonard Y et al. (2013) Mitigating fluorescence spectral overlap in wide-field endoscopic imaging. J Biomed Opt 18:86012